The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

William J. Burman

Infectious Diseases Clinic of Denver Public Health and Division of Infectious Diseases

University of Colorado




Name/email consistency: high



  • Infectious Diseases Clinic of Denver Public Health and Division of Infectious Diseases, University of Colorado, Denver, USA. 2010
  • Infectious Disease Clinic, Denver Public Health, Denver, Colorado 80204, USA. 2009
  • Denver Public Health, 605 Bannock Street, Denver, CO 80204, USA. 2001 - 2008
  • Denver Public Health Department and the Department of Medicine, University of Colorado Health Sciences Center, Denver, USA. 1998 - 2008
  • Division of Infectious Diseases, University of Colorado Health Sciences Center, 4200 East Ninth Avenue, Denver, USA. 2005
  • Department of Public Health, Denver Health and Hospital Authority, USA. 2000 - 2003


  1. Rip Van Winkle wakes up: development of tuberculosis treatment in the 21st century. Burman, W.J. Clin. Infect. Dis. (2010) [Pubmed]
  2. Relapse associated with active disease caused by Beijing strain of Mycobacterium tuberculosis. Burman, W.J., Bliven, E.E., Cowan, L., Bozeman, L., Nahid, P., Diem, L., Vernon, A. Emerging Infect. Dis. (2009) [Pubmed]
  3. Episodic antiretroviral therapy increases HIV transmission risk compared with continuous therapy: results of a randomized controlled trial. Burman, W., Grund, B., Neuhaus, J., Douglas, J., Friedland, G., Telzak, E., Colebunders, R., Paton, N., Fisher, M., Rietmeijer, C. J. Acquir. Immune Defic. Syndr. (2008) [Pubmed]
  4. The impact of episodic CD4 cell count-guided antiretroviral therapy on quality of life. Burman, W.J., Grund, B., Roediger, M.P., Friedland, G., Darbyshire, J., Wu, A.W. J. Acquir. Immune Defic. Syndr. (2008) [Pubmed]
  5. Ensuring the involvement of children in the evaluation of new tuberculosis treatment regimens. Burman, W.J., Cotton, M.F., Gibb, D.M., Walker, A.S., Vernon, A.A., Donald, P.R. PLoS Med. (2008) [Pubmed]
  6. Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis. Burman, W., Weis, S., Vernon, A., Khan, A., Benator, D., Jones, B., Silva, C., King, B., LaHart, C., Mangura, B., Weiner, M., El-Sadr, W. Int. J. Tuberc. Lung Dis. (2007) [Pubmed]
  7. Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis. Burman, W., Benator, D., Vernon, A., Khan, A., Jones, B., Silva, C., Lahart, C., Weis, S., King, B., Mangura, B., Weiner, M., El-Sadr, W. Am. J. Respir. Crit. Care Med. (2006) [Pubmed]
  8. Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis. Burman, W.J., Goldberg, S., Johnson, J.L., Muzanye, G., Engle, M., Mosher, A.W., Choudhri, S., Daley, C.L., Munsiff, S.S., Zhao, Z., Vernon, A., Chaisson, R.E. Am. J. Respir. Crit. Care Med. (2006) [Pubmed]
  9. Issues in the management of HIV-related tuberculosis. Burman, W.J. Clin. Chest Med. (2005) [Pubmed]
  10. The effects of local review on informed consent documents from a multicenter clinical trials consortium. Burman, W., Breese, P., Weis, S., Bock, N., Bernardo, J., Vernon, A. Control. Clin. Trials (2003) [Pubmed]
  11. Conventional and molecular epidemiology of trimethoprim-sulfamethoxazole resistance among urinary Escherichia coli isolates. Burman, W.J., Breese, P.E., Murray, B.E., Singh, K.V., Batal, H.A., MacKenzie, T.D., Ogle, J.W., Wilson, M.L., Reves, R.R., Mehler, P.S. Am. J. Med. (2003) [Pubmed]
  12. Clinical and radiographic features of HIV-related tuberculosis. Burman, W.J., Jones, B.E. Semin. Respir. Infect (2003) [Pubmed]
  13. Lack of toxicity from concomitant directly observed disulfiram and isoniazid-containing therapy for active tuberculosis. Burman, W.J., Terra, M., Breese, P., Cohn, D., Reves, R. Int. J. Tuberc. Lung Dis. (2002) [Pubmed]
  14. Breaking the camel's back: multicenter clinical trials and local institutional review boards. Burman, W.J., Reves, R.R., Cohn, D.L., Schooley, R.T. Ann. Intern. Med. (2001) [Pubmed]
  15. Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials. Burman, W.J., Gallicano, K., Peloquin, C. Clin. Pharmacokinet (2001) [Pubmed]
  16. Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy. Burman, W.J., Jones, B.E. Am. J. Respir. Crit. Care Med. (2001) [Pubmed]
  17. Hepatotoxicity from rifampin plus pyrazinamide: lessons for policymakers and messages for care providers. Burman, W.J., Reves, R.R. Am. J. Respir. Crit. Care Med. (2001) [Pubmed]
  18. Review of false-positive cultures for Mycobacterium tuberculosis and recommendations for avoiding unnecessary treatment. Burman, W.J., Reves, R.R. Clin. Infect. Dis. (2000) [Pubmed]
  19. Therapeutic implications of drug interactions in the treatment of human immunodeficiency virus-related tuberculosis. Burman, W.J., Gallicano, K., Peloquin, C. Clin. Infect. Dis. (1999) [Pubmed]
  20. The case for conservative management of early HIV disease. Burman, W.J., Reves, R.R., Cohn, D.L. JAMA (1998) [Pubmed]
WikiGenes - Universities